Hosted on MSN35m
Amgen Shrugs Off A Surprise Setback For One Of Its Obesity DrugsAmgen stock rose early Wednesday, though the biotech behemoth said the FDA placed one of its obesity treatments on clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback